Articles related to OBESITY/WEIGHT MANAGEMENT

The Epitomee capsule, a novel ingestible device for weight management, has shown promising results in clinical trials, with 55.5% of users losing at least 5% of their baseline body weight at 24 weeks.

A 2023 study found that participants who consumed fast food for 20% or more of their meals accumulated excessive fat in their livers, highlighting the potential impact of dietary choices on liver health.

Recent studies indicate that stevia, unlike some artificial sweeteners, does not increase appetite or decrease satiety, potentially aiding in weight management efforts.

Semaglutide medications, while effective for weight loss, may carry unexpected mental health risks that require careful monitoring and consideration in clinical practice.

A recent study shows that combining meal replacement therapy with financial incentives led to a 6 percentage point greater reduction in BMI for adolescents with severe obesity compared to meal replacement therapy alone.

Semaglutide may alter taste perception gene expression in the tongue and modify brain reactions to sweet tastes, potentially enhancing weight loss effects beyond appetite suppression.